2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials
Importance Nonrandomized studies using insurance claims databases can be analyzed to
produce real-world evidence on the effectiveness of medical products. Given the lack of …
produce real-world evidence on the effectiveness of medical products. Given the lack of …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …
Review included limited searches for new evidence and discussion of the search results …
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …
SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial …
AM Young, A Marshall, J Thirlwall… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term
daily subcutaneous low molecular weight heparin has been standard treatment for such …
daily subcutaneous low molecular weight heparin has been standard treatment for such …
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
[HTML][HTML] Rivaroxaban with or without aspirin in stable cardiovascular disease
Background We evaluated whether rivaroxaban alone or in combination with aspirin would
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …